Mudit Sabharwal says: Before we prescribe GLP-1s, we screen for eating disorders
Current NHS eligibility criteria for semaglutide 2.4 mg (Wegovy) for weight management, according to NICE TA875, include: Body Mass Index (BMI) 35 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea) For people from certain high-risk ethnic groups (such as South Asian, Chinese, Black African, or African-Caribbean), lower BMI thresholds apply (typically reduced by 2.5 kg/m) Treatment must be prescribed within specialist weight management services only Treatment is limited to a maximum duration of 2 years Must be used as an adjunct to a reduced-calorie diet and increased physical activity Liraglutide 3 mg (Saxenda) availability varies significantly across NHS regions and is not routinely commissioned in many areas
Best Places to Buy Research-Grade BPC-157 in 2026 Here are the three direct research vendors that come up most often when researchers look for this peptide, ranked by the strength of their lab proof and how easy they are to order from
J Biol Chem 267: 7402-7405, 1992
Lancet 398 , 143155 (2021)
Depending on the product and the guidance of a healthcare provider, readers can easily scale from one capsule daily to two or three capsules if their goals or circumstances call for a higher intake
